Qu D

No ORCID on file · 8 papers in corpus
observational 2024
BMC women's health ·doi:10.1186/s12905-024-03221-w

BACKGROUND: To investigate the impact of chronic endometritis (CE) on the recurrence of endometrial polyps (EPs) in premenopausal women after transcervical resection of endometrial polyps (TCRP). METHODS: This prospective study enrolled 50…

case-report 2024
Asian biomedicine : research, reviews and news ·doi:10.2478/abm-2024-0004

BACKGROUND: Ectopic pregnancy (EP), reflecting a fertilized ovum implanted outside the normal uterine cavity, represents a frequent cause of morbidity and possibly mortality in women of reproductive age. OBJECTIVE: To summarize the diagnos…

observational 2023
BMC women's health ·doi:10.1186/s12905-023-02232-3

BACKGROUND: The reported recurrence rate of endometrial polyps (EPs) after hysteroscopic polypectomy varied widely, and the factors influencing the recurrence of EPs are still controversial. Furthermore, the known definite independent risk …

observational 2022
·doi:10.21203/rs.3.rs-1578380/v1

Objective: To evaluate the impact of chronic endometritis (CE) on the recurrence of endometrial polyps (EPs) in premenopausal women who underwent hysteroscopic polypectomy. Methods: : We conducted a retrospective observational cohort study…

other 2022
BMC microbiology ·doi:10.1186/s12866-021-02423-8

BACKGROUND: Previous reports have demonstrated two thiazolidione derivatives (H2-60 and H2-81) can robustly inhibit the planktonic growth and biofilm formation of S. epidermidis and S. aureus by targeting the histidine kinase YycG. Whereas …

observational 2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00728-x

BACKGROUND: A rapid development in assisted reproductive technology (ART) has led to a surge in its popularity among target couples. However, elucidation on the molecular mechanism and effective solutions for a common problem posed by ART, …

observational 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.618580

OBJECTIVE: To verify if patients with deep ovarian suppression following gonadotropin releasing hormone (GnRH) agonist long protocol may benefit from a modified GnRH antagonist protocol based on luteinizing hormone (LH) levels. DESIGN: Ret…

rct 2020
The Journal of international medical research ·doi:10.1177/0300060520926026

ObjectiveTo evaluate the efficacy and safety of multiple- versus single-dose gonadotropin-releasing hormone agonist (GnRH-a) addition to luteal phase support (LPS), in patients with a first in vitro fertilization (IVF) failure associated wi…